OpenAI is pouring over $20 billion into Cerebras, the AI chip manufacturer, in a three-year deal that could hand it roughly an 11% equity stake in the company.
The commitment isn’t starting from scratch. It builds on an earlier agreement from January 2026, valued at over $10 billion, which secured OpenAI 750 megawatts of compute capacity from Cerebras. This latest expansion effectively triples the financial scope of that relationship and introduces something new: an ownership position in the chipmaker itself.
Why OpenAI is buying chips and buying in
By negotiating an equity stake of between 10% and 11%, OpenAI is turning a vendor relationship into something closer to a strategic alliance.
Cerebras is planning to go public in May 2026, part of a broader wave of tech IPOs that includes companies like SpaceX. That wave is estimated to be worth around $2 trillion in total listings.
Cerebras has built its reputation on chips designed specifically for large-scale AI model training. Its wafer-scale engine, which uses an entire silicon wafer as a single chip rather than cutting it into smaller pieces, is purpose-built for the kind of massive workloads that companies like OpenAI run daily.
The funding arms race behind the deal
OpenAI raised $122 billion in Q1 2026 at a post-money valuation of $852 billion, making it one of the largest funding rounds in history by any company, in any industry, ever.
In Q1 2026, four companies — OpenAI, Anthropic, xAI, and Waymo — captured roughly 65% of all venture capital funding.
What this means for investors
The Cerebras IPO just got a lot more interesting. Having OpenAI as both a major customer and a significant shareholder provides revenue visibility and strategic validation. A guaranteed $20 billion-plus in revenue commitments over three years gives potential public market investors something concrete to underwrite.
When a single customer represents that large a portion of revenue, concentration risk becomes a real concern. Public market investors will want to see a diversified customer base before assigning a premium valuation.